ATS
DGX icon

Ashton Thomas Securities’s Quest Diagnostics DGX Stock Holding History

Ashton Thomas Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-114
Closed -$17.7K – 465
2024
Q3 		$17.7K Buy
+114
New +$17K ﹤0.01% 660

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ashton Thomas Securities's DGX Position: Q4 2024 in Review

Ashton Thomas Securities sold out of Quest Diagnostics (DGX) in Q4 2024, closing a stake of 114 shares — an estimated $17.7K sold.

Ashton Thomas Securities first reported a position in DGX in Q3 2024 and held it in 1 quarter. The position peaked at $17.7K in Q3 2024. 895 funds tracked by Wall St. Rank hold DGX as of Q4 2024.

  • Ashton Thomas Securities reported no remaining Quest Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Ashton Thomas Securities sold 114 Quest Diagnostics shares in Q4 2024, an estimated $17.7K.
  • Ashton Thomas Securities first reported a position in Quest Diagnostics in Q3 2024 and held it in 1 quarter.
  • Ashton Thomas Securities's Quest Diagnostics position peaked at $17.7K in Q3 2024.
  • 895 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.

Based on Ashton Thomas Securities's 13F filing for Q4 2024, filed 11 Feb 2025.